z-logo
Premium
Amelioration of experimental autoimmune encephalomyelitis in Lewis rats treated with fucoidan
Author(s) -
Kim Heechul,
Moon Changjong,
Park Eunjin,
Jee Youngheun,
Ahn Meejung,
Wie Myung Bok,
Shin Taekyun
Publication year - 2010
Publication title -
phytotherapy research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.019
H-Index - 129
eISSN - 1099-1573
pISSN - 0951-418X
DOI - 10.1002/ptr.2959
Subject(s) - fucoidan , experimental autoimmune encephalomyelitis , medicine , immunology , multiple sclerosis , cytokine , encephalomyelitis , adjuvant , myelin oligodendrocyte glycoprotein , pharmacology , biology , polysaccharide , biochemistry
We examined whether fucoidan affected the clinical symptoms of experimental autoimmune encephalomyelitis (EAE) in rats. EAE was induced in Lewis rats that were immunized with guinea‐pig myelin basic protein (MBP) and complete Freund's adjuvant. Fucoidan (50 mg/kg, daily) was administered to rats with EAE intraperitoneally, either in the EAE induction phase from either 1 day before immunization to day 7 post‐immunization (PI), or the effector phase from day 8 to 14 PI, to test which phase of rat EAE is affected by fucoidan treatment. The onset, severity and duration of EAE paralysis in the fucoidan‐treated group in the days 8–14 PI‐treated rats, but not in days −1–7 PI‐treated rats, were significantly delayed, suppressed and reduced, respectively, compared with the vehicle‐treated controls. Treatment with fucoidan reduced the encephalitogenic response and TNF‐α production during EAE. Moreover, the clinical amelioration coincided with decreased infiltration of inflammatory cells in the EAE‐affected spinal cord. The ameliorative effect of fucoidan on clinical paralysis in EAE‐affected rats may be mediated, in part, by the suppression of the autoreactive T cell response and inflammatory cytokine production. Copyright © 2009 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here